WangX, IoacaraS, DeHennisA: Long-term home study on nocturnal hypoglycemic alarms using a new fully implantable continuous glucose monitoring system in type 1 diabetes. Diabetes Technol Ther, 2015; 17:780–786.
2.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care, 2010; 33:17–22.
3.
YehHC, BrownTT, MaruthurN, et al.: Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med, 2012; 157:336–347.
4.
Fiallo-ScharerR, ChengJ, BeckRW, et al.: Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care, 2011; 34:586–590.
5.
HovorkaR: Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol, 2011; 7:385–395.
LeeSW, WelshJB: Upcoming devices for diabetes management: the artificial pancreas as the hallmark device. Diabetes Technol Ther, 2015; 17:538–541.
8.
PeyserT, DassauE, BretonM, et al.: The artificial pancreas: current status and future prospects in the management of diabetes. Ann N Y Acad Sci, 2014; 1311:102–123.
9.
ShahVN, ShoskesA, TawfikB, et al.: Closed-loop system in the management of diabetes: past, present, and future. Diabetes Technol Ther, 2014; 16:477–490.
10.
PhillipM, BattelinoT, AtlasE, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med, 2013; 368:824–833.
11.
KovatchevBP, RenardE, CobelliC, et al.: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care, 2013; 36:1851–1858.
12.
ThabitH, TauschmannM, AllenJM, et al.: Home use of an artificial beta cell in type 1 diabetes. N Engl J Med, 2015September17 [Epub ahead of print] doi: 10.1056/NEJMoa1509351.
13.
RussellSJ, El-KhatibFH, NathanDM, et al.: Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care, 2012; 35:2148–2155.
14.
RussellSJ, El-KhatibFH, SinhaM, et al.: Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med, 2014; 371:313–325.
15.
HaidarA, LegaultL, MessierV, et al.: Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol, 2015; 3:17–26.
16.
HaidarA, LegaultL, Matteau-PelletierL, et al.: Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol, 2015; 3:595–604.
17.
BarnardKD, WysockiT, AllenJM, et al.: Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care, 2014; 2:e000025.
18.
BarnardKD, WysockiT, ThabitH, et al.: Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with type 1 diabetes in the home setting. Diabet Med, 2015; 32:601–608.
19.
DamianoER, McKeonK, El-KhatibFH, et al.: A comparative effectiveness analysis of three continuous glucose monitors: the Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol, 2014; 8:699–708.
20.
BequetteBW: Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control, 2012; 36:255–266.
21.
MortellaroM, DeHennisA: Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes. Biosens Bioelectron, 2014; 61:227–231.
22.
BaileyTS, ChangA, ChristiansenM: Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol, 2015; 9:209–214.
23.
ThabitH, LeelarathnaL, WilinskaME, et al.: Accuracy of continuous glucose monitoring during three closed-loop home studies under free-living conditions. Diabetes Technol Ther, 2015; 14:801–807.
24.
BaileyT, BodeBW, ChristiansenMP, et al.: The performance and usability of a factory-calibrated flash glucose monitoring system. Diabetes Technol Ther, 2015; 17:787–794.
